

Oligonucleotide Synthesis Services Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
The Oligonucleotide Synthesis Services market is experiencing significant growth, driven by advancements in genetic research and biopharmaceutical development. As of 2023, the market size is estimated to reach approximately $2.5 billion, fueled by increasing demand for personalized medicine and highthroughput sequencing technologies, enhancing applications across diagnostics and therapeutics.
Request Sample Report
◍ Genescript
◍ GeneArt (Thermofischer)
◍ Renesas Electronics Corporation
◍ DNA 2.0 (ATUM)
◍ OriGene
◍ BBI
◍ Genewiz
◍ Eurofins Genomics
◍ Gene Oracle
◍ SBS Genetech
◍ Bio Basic
The Oligonucleotide Synthesis Services Market is competitive, featuring companies like GeneScript, Thermo Fisher's GeneArt, Renesas Electronics, ATUM's DNA 2.0, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, and Bio Basic. They enhance the market through innovation, diverse offerings, and operational efficiencies.
- GeneScript: ~$250 million revenue
- Eurofins Genomics: ~$1.5 billion revenue
- Genewiz: Part of ~$800 million revenue (Eurofins)
Request Sample Report
◍ Primers
◍ Probes
◍ Intermediate-scale Synthesis Oligos
◍ Large-scale Synthesis Oligos ◍ Linkers and Adaptors ◍ Commercial ◍ Academic Research Request Sample Report
Request Sample Report
$ 1.72 Billion